Press Release
Leading clinical immunotherapies developer Ramy Ibrahim joins 不良研究所 as Chief Medical Officer
Press release announcing appointment of Dr Ramy Ibrahim, MD, as Chief Medical Officer.
11.02.2021Press release announcing appointment of Dr Ramy Ibrahim, MD, as Chief Medical Officer.
